Todos Medical Ltd (OP: TOMDF )
0.0620
USD
-0.0010
(-1.59%)
Streaming Delayed Price
Updated: 11:22 AM EST, Jan 25, 2021
Add to My Watchlist
All news about Todos Medical Ltd
From NewMediaWire
Todos Medical Announces $4.8 Million in Sales for December 2020, a 50% Month Over Month Increase in Sales from November 2020
January 11, 2021
From NewMediaWire
Todos Medical Announces Agreement to Supply Natural Wellness Clinics with COVID-19 Testing Products to Support Initiatives in the Commonwealth of Kentucky
December 23, 2020
From NewMediaWire
Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore for COVID-19 Immune Monitoring Service
December 14, 2020
From NewMediaWire
Broad Diagnostic Measures Remain Crucial as Vaccinations Near
December 07, 2020
From PR Newswire
Todos Medical Announces Commercial Launch of Proprietary 3CL Protease Inhibitor Dietary Supplement Tollovid at The Alchemist's Kitchen
December 07, 2020
From NewMediaWire
Comprehensive Diagnostics Remains a Priority As More Surges are Expected
December 03, 2020
From PR Newswire
A New Surge in Cases Emphasizes the Need for Effective Diagnostics
December 02, 2020
From PR Newswire
Todos Medical Announces $3.2 Million in Sales for November 2020, a 269% Increase Sequential Month over Month Sales Growth from October 2020
December 02, 2020
From NewMediaWire
Todos Medical Provides Strategic Outlook
December 01, 2020
From NewMediaWire
Todos Medical Provides Strategic Outlook
December 01, 2020
Todos Medical Completes Installation of Lab Automation Equipment at Wisconsin Lab Client to Support COVID-19 PCR Testing
November 24, 2020
From NewMediaWire
More Stringent Testing is Needed as Regions Head for More Lockdowns
November 23, 2020
From PR Newswire
Todos Medical Announces Positive In Vitro Data for Tollovid Confirming 3CL Protease Inhibition Mechanism of Action
November 20, 2020
From NewMediaWire
The Need for Precise Testing Capabilities is Clear as Cases Surge
November 19, 2020
From PR Newswire
Rising Number of Cases Reinforces the Need for Comprehensive Diagnostics
November 18, 2020
From PR Newswire
Todos Medical Announces Positive Initial Clinical Proof-of-Concept Data for a Rapid SARS-CoV-2 3CL Protease Detection Assay
November 18, 2020
From NewMediaWire
From PR Newswire
Todos Medical Announces Clinical Validation and National CLIA Certification for MOTO+PARA Mobile High Complexity Labs
November 17, 2020
From NewMediaWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker, Inc.
Broker/Dealer, SEC Registered Investment Advisor, MSRB Registered Company | Member FINRA, SIPC
Accounts are carried by Pershing LLC, member FINRA, NYSE, SIPC, a wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon)
Accounts carried by Raymond James & Associates, Inc., member New York Stock Exchange / SIPC
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker, Inc.
Broker/Dealer, SEC Registered Investment Advisor, MSRB Registered Company | Member FINRA, SIPC
Accounts are carried by Pershing LLC, member FINRA, NYSE, SIPC, a wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon)
Accounts carried by Raymond James & Associates, Inc., member New York Stock Exchange / SIPC